Suvretta Capital Management, LLC Ionis Pharmaceuticals Inc Transaction History
Suvretta Capital Management, LLC
- $2.54 Billion
- Q3 2024
A detailed history of Suvretta Capital Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 10,800 shares of IONS stock, worth $382,968. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,800
Previous 10,800
-0.0%
Holding current value
$382,968
Previous $514,000
15.95%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
404Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$534 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$502 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$366 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$310 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$279 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.03B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...